Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Gelone SP, Mariano D, Baba T, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. Howard-Anderson J, et al. Among authors: baba t. Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692. Clin Infect Dis. 2023. PMID: 36031403 Free PMC article.
Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study.
Bradley JS, Orchiston E, Portsmouth S, Ariyasu M, Baba T, Katsube T, Makinde O. Bradley JS, et al. Among authors: baba t. Pediatr Infect Dis J. 2024 Sep 4;44(2):136-42. doi: 10.1097/INF.0000000000004529. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 39230271 Free PMC article.
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, phase 2 clinical trial.
Kato M, Nakagome K, Baba T, Sonoyama T, Okutsu D, Yamanaka H, Shimizu R, Motomiya T, Inoue T. Kato M, et al. Among authors: baba t. Psychiatry Clin Neurosci. 2023 Sep;77(9):497-509. doi: 10.1111/pcn.13569. Epub 2023 Jun 21. Psychiatry Clin Neurosci. 2023. PMID: 37252829 Free PMC article. Clinical Trial.
Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials.
Tanaka K, Baba T, Yoshida M, Iguchi M, Sonoyama T, Fukuhara T, Kano T. Tanaka K, et al. Among authors: baba t. Curr Med Res Opin. 2022 Feb;38(2):303-310. doi: 10.1080/03007995.2021.2012964. Epub 2021 Dec 22. Curr Med Res Opin. 2022. PMID: 34904508 Free article. Clinical Trial.
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis.
Longshaw C, Santerre Henriksen A, Dressel D, Malysa M, Silvestri C, Takemura M, Yamano Y, Baba T, Slover CM. Longshaw C, et al. Among authors: baba t. Microbiol Spectr. 2023 Dec 12;11(6):e0237123. doi: 10.1128/spectrum.02371-23. Epub 2023 Nov 15. Microbiol Spectr. 2023. PMID: 37966262 Free PMC article.
2,660 results